theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

HHT   

Questions discussed in this category


How would you manage HHT with ongoing epistaxis despite IV bevacizumab, with a history of superficial thrombosis?
Has undergone cauterization with ENT, also topical/intranasal bevacizumab, and rose geranium oil. IV bevacizumab was initially helpful, but now with b...
2 Answers available

What is your approach to follow up after embolization of pulmonary AVM in patients with HHT?
2 Answers available

How do you decide between systemic antiangiogenic therapies for HHT?
When would you consider pomalidomide over bevacizumab?
1 Answer available

Do you consider the use of bevacizumab in patients with HHT who have high output cardiac failure related to liver AVMs who also have cerebral AVMs?
1 Answer available
27059244872136113103


Papers discussed in this category


JAMA,
Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.

Ann Intern Med, 2020 Sep 08
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.

Related Topics

  • Pulmonology
  • Pulmonary Vascular Disease
  • Hematology
  • Benign Hematology
  • Cardiology
  • Genetic Liver Disease
  • Anemia
  • Pediatric Hematology/Oncology
  • Pediatric Hematology
  • ENT

Copyright © 2026 theMednet
All Rights Reserved.